tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market
KAPA
Kairos Pharma, Ltd.
RESEARCH TOOLSreports

Kairos Pharma, Ltd. (KAPA) Income Statement

138 Followers

Kairos Pharma, Ltd. Income Statement

Last quarter (Q4 2025), Kairos Pharma, Ltd.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Kairos Pharma, Ltd.'s net income was $-1.36M. See Kairos Pharma, Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -160.00K$ -160.00K$ -160.00K$ -98.00K
Operating Expenses
$ 5.57M$ 2.18M$ 1.55M$ 411.00K$ 1.84M
Depreciation and Amortization
$ 160.00K$ 160.00K$ 160.00K$ 160.00K$ 98.00K
EBITDA
$ -5.29M$ -1.58M$ -1.55M$ -411.00K$ -1.84M
Operating Income
$ -5.57M$ -2.34M$ -1.71M$ -571.00K$ -1.94M
Other Income/Expenses
$ 125.00K$ -260.00K$ -98.00K$ -479.00K$ -202.00K
Pretax Income
$ -5.45M$ -2.60M$ -1.81M$ -1.05M$ -2.15M
Net Income
$ -5.45M$ -2.60M$ -1.81M$ -1.05M$ -2.15M
Per Share Metrics
Basic EPS
$ -0.30$ -0.23$ -0.17$ -0.10$ -0.17
Diluted EPS
$ -0.30$ -0.23$ -0.17$ -0.10$ -0.17
Weighted Average Shares Outstanding
 18.43M 11.36M 10.38M 10.24M 12.84M
Weighted Average Shares Outstanding (Diluted)
 18.43M 11.36M 10.38M 10.24M 12.84M
Currency in USD

Kairos Pharma, Ltd. Earnings and Revenue History